General Information
Sagimet SB2640-CLIN-007
A Phase 2B, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of TVB-2640 in Subjects with Nonalcoholic Steatohepatitis (Fascinate-2)
| Protocol | SB2640-CLIN-007 |
|---|---|
| Identifier | Project Code: 7015424 |
| UID | 324eccdb-9ce9-46b5-84c1-2bb108ac26f7 |
| Status | Done - Archived |
| Phase | 2B |
| Category | NASH / Adult |
| Launch Year | 2021 |
| NCT Number | - |
| Created | 2021-04-16 15:07 |
| Last Updated | 2023-06-21 16:21 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | 2021-05-27 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2021-05-03 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2023-04-10 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | - | No | |
| Coordinator | Gallardo, Michael | MGallardo | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Sagimet Biosciences |
|---|---|
| Division | Sagimet Biosciences |
| Team | Sagimet Biosciences |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Syneos Health |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
